VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NVS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NVSNovartis AG
$157.03$299.6B
Overview & Verdict
OverviewShould I Buy?
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNVSPrice Target
NVS logo

Novartis AG (NVS) Price Target Analysis

Updated Jul 2, 2026
Analyst Rating: Hold
Based on 25 analysts

8.3% Below Target

NVS trades 8.3% below Wall Street's consensus target of $170.00.

Current Price$157.03
Average Target$170.00
Low$170.00
Median$170.00
High$170.00

Analyst Target Range

Forward P/E18.0x
(Fair)
PEG Ratio1.17
(Fair)
Implied Growth+23.3%
(Moderate)
Analyst Spread0.0%
(High Agreement)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$157.03
Consensus$170.00
High$170.00
Low$170.00

Consensus Scenario Assumptions

The base valuation assumes NVS achieves its forward estimates and maintains a stable P/E multiple of 18.0x. This scenario reflects the blended consensus of 25 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 25 published analyst recommendations for NVS

68% hold / mixed conviction
+8
BearishBullish
Weighted analyst sentiment score based on 25 ratings
ConsensusHold
Coverage25 Analysts
Net Score+8
Bull / Bear24% / 8%
Strong Buy00%
Buy624%
Hold1768%
Sell28%
Strong Sell00%
Strong Buy
00%
Buy
624%
Hold
1768%
Sell
28%
Strong Sell
00%
Recommendation Mix24% Buy · 68% Hold · 8% Sell
Buy (6)Hold (17)Sell (2)

NVS Price Target Analysis

Updated July 8, 2026

As of July 8, 2026, Novartis AG (NVS) has a Wall Street consensus price target of $170.00, based on estimates from 25 covering analysts. With the stock currently trading at $157.03, this represents a potential upside of +8.3%. The company has a market capitalization of $299.63B.

Analyst price targets range from a low of $170.00 to a high of $170.00, representing a 0% spread in expectations. The median target of $170.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.

The current analyst consensus rating is Hold, with 6 analysts rating the stock as a Buy or Strong Buy,17 rating it Hold, and 2 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.

From a valuation perspective, NVS trades at a trailing P/E of 21.8x and forward P/E of 18.0x. The forward PEG ratio of 1.17 indicates reasonable valuation for growth. Analysts expect EPS to grow +23.3% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $185.30, with bear and bull scenarios of $116.74 and $244.15 respectively. Model confidence stands at 51/100, reflecting moderate uncertainty in projections.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+6.2%
Industry Consensus
Avg Forward P/E
15.8x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
PFE logo
PFEPfizer Inc.
$136.9B$24.07$26.75
+11.1%
Hold8.1x39
AZN logo
AZNAstraZeneca PLC
$299.4B$193.12$186.67
-3.3%
Buy18.8x41
NVO logo
NVONovo Nordisk A/S
$220.6B$49.64$45.00
-9.3%
Buy2.3x39
SNY logo
SNYSanofi
$103.3B$42.98$51.00
+18.7%
Hold10.2x27
GSK logo
GSKGSK plc
$107.2B$53.32$52.45
-1.6%
Hold14.8x29
MRK logo
MRKMerck & Co., Inc.
$318.3B$128.86$133.77
+3.8%
Buy25.1x37
LLY logo
LLYEli Lilly and Company
$1.2T$1235.56$1269.94
+2.8%
Buy33.7x45
ABT logo
ABTAbbott Laboratories
$166.9B$95.84$125.62
+31.1%
Buy17.5x41
BMY logo
BMYBristol-Myers Squibb Company
$118.4B$57.97$62.60
+8.0%
Hold9.2x41
ABBV logo
ABBVAbbVie Inc.
$449.9B$254.65$258.00
+1.3%
Buy17.9x41

NVS — Frequently Asked Questions

Quick answers to the most common questions about buying NVS stock.

What is the NVS stock price target for 2026?

The consensus price target for NVS is $170, close to the current price of $157.03 (8.3% implied move). Based on 25 analyst estimates, the stock appears fairly valued near current levels.

Is NVS a buy, sell, or hold?

NVS has a consensus rating of "Hold" based on 25 Wall Street analysts. The rating breakdown is mixed, with 17 Hold ratings making up the largest segment. The consensus 12-month price target of $170 implies 8.3% upside from current levels.

Is NVS stock overvalued or undervalued?

With a forward P/E of 18.0366x, NVS trades at a relatively low valuation. The consensus target of $170 implies 8.3% appreciation, suggesting the market may be pricing in risks.

How high can NVS stock go?

The most bullish Wall Street analyst has a price target of $170 for NVS, while the most conservative target is $170. The consensus of $170 represents the median expectation. Our quantitative valuation model projects a bull case target of $244 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover NVS stock?

NVS is heavily covered by Wall Street, with 25 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 17 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the NVS stock forecast?

The 12-month NVS stock forecast based on 25 Wall Street analysts shows a consensus price target of $170, with estimates ranging from $170 (bear case) to $170 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $185, with bear/bull scenarios of $117/$244.

What is NVS's fair value based on fundamentals?

Our quantitative valuation model calculates NVS's fair value at $185 (base case), with a bear case of $117 and bull case of $244. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 51/100.

What is NVS's forward P/E ratio?

NVS trades at a forward P/E ratio of 18.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 21.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy NVS stock?

NVS appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $170 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do NVS price targets vary so much?

NVS analyst price targets range from $170 to $170, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $170 consensus represents the middle ground. Our model's $117-$244 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools

Should I Buy NVS?

Wall Street verdict, signals, and target summaries.

See Verdict

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare